Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis

Area of Science:

• Hematology
• Oncology
• Stem Cell Biology

Background:

• Human malignancies arise from accumulated somatic mutations.
• Hematopoietic stem cells (HSCs) are implicated in myeloid malignancy development.
• Recent evidence suggests HSCs are also critical in mature lymphoid malignancies.

Purpose of the Study:

• To investigate the role of hematopoietic stem cells (HSCs) in the pathogenesis of mature lymphoid malignancies.
• To highlight HSCs as a critical cellular target in oncogenic processes for hematological malignancies.
• To consider the impact of aging HSCs on age-associated hematological malignancies.

Main Methods:

• Review of existing literature on HSCs and hematological malignancies.
• Analysis of previous findings on clonal B cell generation in chronic lymphocytic leukemia (CLL) patients.
• Examination of reported HSC involvement in mature T cell lymphomas.

Main Results:

• HSCs accumulate critical somatic mutations, driving myeloid malignancy.
• Clonal B cell propensity in CLL originates at the HSC stage.
• HSCs are implicated in the pathogenesis of mature T cell lymphomas.

Conclusions:

• HSCs are a critical cellular target in the oncogenic process for most, if not all, mature lymphoid malignancies.
• The role of aging HSCs must be considered in the stepwise transformation of age-associated hematological malignancies.